| Income Statement |
| Total Revenue | 460.08M |
|
| Revenues (USD) | 460.08M |
| Cost of Revenue | 322.31M |
| Gross Profit | 137.77M |
| Operating Expenses | 47.48M |
| Research and Development Expense | 23.57M |
| Selling, General and Administrative Expense | 23.91M |
| Operating Income | 90.29M |
| Income Tax Expense | 15.57M |
| Net Income | 90.77M |
| Net Income Common Stock | 90.77M |
| Net Income Common Stock (USD) | 90.77M |
| Consolidated Income | 90.62M |
| Net Income to Non-Controlling Interests | -150.00K |
| Earnings per Basic Share | 0.80 |
| Earnings per Basic Share (USD) | 0.80 |
| Earnings per Diluted Share | 0.79 |
| Earning Before Interest & Taxes (EBIT) | 106.34M |
| Earning Before Interest & Taxes (USD) | 106.34M |
| Weighted Average Shares | 112.91M |
| Weighted Average Shares Diluted | 114.43M |
| Balance Sheet |
| Cash and Equivalents | 231.19M |
| Cash and Equivalents (USD) | 231.19M |
| Investments | 1.25B |
| Investments Current | 1.25B |
| Trade and Non-Trade Receivables | 202.87M |
| Current Assets | 1.99B |
| Property, Plant & Equipment Net | 1.65B |
| Total Assets | 3.77B |
| Debt Current | 16.92M |
| Total Debt | 141.70M |
| Current Liabilities | 404.21M |
| Debt Non-Current | 124.78M |
| Total Liabilities | 700.06M |
| Shareholders Equity | 3.07B |
| Shareholders Equity (USD) | 3.07B |
| Assets Non-Current | 1.79B |
| Total Debt (USD) | 141.70M |
| Deferred Revenue | 176.04M |
| Inventory | 244.36M |
| Liabilities Non-Current | 295.85M |
| Trade and Non-Trade Payables | 122.61M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 83.57M |
| Net Cash Flow from Financing | -11.11M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.12M |
| Capital Expenditure | -186.58M |
| Issuance (Repayment) of Debt Securities | -11.11M |
| Net Cash Flow from Investing | -176.58M |
| Net Cash Flow - Investment Acquisitions and Disposals | 10.00M |
| Net Cash Flow from Operations | 176.97M |
| Effect of Exchange Rate Changes on Cash | -1.39M |